The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

PubWeight™: 8.43‹?› | Rank: Top 0.1%

🔗 View Article (PMID 16424409)

Published in Chest on January 01, 2006


Harold S Nelson1, Scott T Weiss, Eugene R Bleecker, Steven W Yancey, Paul M Dorinsky, SMART Study Group

Author Affiliations

1: National Jewish Medical and Research Center, Denver, CO, USA.

Articles citing this

(truncated to the top 100)

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet (2009) 2.82

Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38

Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol (2007) 2.24

Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax (2009) 2.12

Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82

International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79

The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population. J Allergy Clin Immunol (2012) 1.76

β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model. Am J Respir Cell Mol Biol (2012) 1.73

Racial differences in quality of life in patients with COPD. Chest (2011) 1.64

Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med (2011) 1.63

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther (2007) 1.61

Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. Am J Respir Crit Care Med (2006) 1.59

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2010) 1.58

Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A (2009) 1.53

Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis (2011) 1.51

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med (2014) 1.48

New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol (2011) 1.46

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med (2006) 1.46

Impact of Age and Sex on Response to Asthma Therapy. Am J Respir Crit Care Med (2015) 1.43

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40

The evidence on tiotropium bromide in asthma: from the rationale to the bedside. Multidiscip Respir Med (2017) 1.39

Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev (2009) 1.33

Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther (2007) 1.30

Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respir Res (2010) 1.21

Safety of indacaterol in the treatment of patients with COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.19

Asthma genetics and personalised medicine. Lancet Respir Med (2014) 1.17

EP4 receptor as a new target for bronchodilator therapy. Thorax (2011) 1.16

A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors. Pharmacogenet Genomics (2008) 1.15

Paediatric prescribing of asthma drugs in the UK: are we sticking to the guideline? Arch Dis Child (2007) 1.15

Activation of endogenous GABAA channels on airway smooth muscle potentiates isoproterenol-mediated relaxation. Am J Physiol Lung Cell Mol Physiol (2008) 1.13

Retracted Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all? Naunyn Schmiedebergs Arch Pharmacol (2008) 1.12

Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. Cochrane Database Syst Rev (2012) 1.11

Informatic tools and approaches in postmarketing pharmacovigilance used by FDA. AAPS J (2008) 1.09

Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir Res (2010) 1.08

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax (2013) 1.08

Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India (2015) 1.07

Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol (2006) 1.06

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev (2012) 1.03

Pharmacogenetics of asthma. Curr Opin Pulm Med (2009) 0.99

Development and characterization of pepducins as Gs-biased allosteric agonists. J Biol Chem (2014) 0.98

Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.98

A call for action: Comparative effectiveness research in asthma. J Allergy Clin Immunol (2010) 0.97

Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J (2010) 0.96

Mechanism regulating proasthmatic effects of prolonged homologous beta2-adrenergic receptor desensitization in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2009) 0.96

Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure. J Allergy Clin Immunol (2010) 0.95

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.95

Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality. Int J Chron Obstruct Pulmon Dis (2007) 0.95

β-Agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent. J Biol Chem (2014) 0.94

Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care. Mayo Clin Proc (2010) 0.93

Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol (2014) 0.92

Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES. Can Fam Physician (2007) 0.90

Nocturnal asthma and the importance of race/ethnicity and genetic ancestry. Am J Respir Crit Care Med (2014) 0.90

Pleiotropic beta-agonist-promoted receptor conformations and signals independent of intrinsic activity. Am J Respir Cell Mol Biol (2006) 0.87

Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med (2010) 0.87

Beta-Adrenergic Agonists. Pharmaceuticals (Basel) (2010) 0.87

beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol (2010) 0.86

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? Drug Des Devel Ther (2013) 0.86

The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells. BMC Immunol (2009) 0.86

Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. Br J Pharmacol (2010) 0.86

The role of pharmacogenomics in improving the management of asthma. J Allergy Clin Immunol (2010) 0.85

Salmeterol and cytokines modulate inositol-phosphate signalling in human airway smooth muscle cells via regulation at the receptor locus. Respir Res (2007) 0.85

GPCRs and arrestins in airways: implications for asthma. Handb Exp Pharmacol (2014) 0.85

Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis (2014) 0.85

Safety of long-acting beta2-agonists in the management of asthma: a Primary Care Respiratory Alliance of Canada perspective. Can Fam Physician (2010) 0.84

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist. Core Evid (2010) 0.84

The pharmacogenetics and pharmacogenomics of asthma therapy. Pharmacogenomics J (2011) 0.84

Asthma control in adults. BMJ (2006) 0.84

Parental perceptions and beliefs about childhood asthma: a cross-sectional study. Croat Med J (2011) 0.83

Genetics of allergic diseases. Immunol Allergy Clin North Am (2014) 0.83

Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice. AAPS J (2015) 0.82

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies. Respir Res (2014) 0.82

Individualized Household Allergen Intervention Lowers Allergen Level But Not Asthma Medication Use: A Randomized Controlled Trial. J Allergy Clin Immunol Pract (2016) 0.81

Ligand bias prevents class equality among beta-blockers. Curr Opin Pharmacol (2014) 0.81

New approaches to managing asthma: a US perspective. Ther Clin Risk Manag (2008) 0.81

Update in asthma 2010. Am J Respir Crit Care Med (2011) 0.81

Genetic variability of the beta2 adrenergic receptor and asthma exacerbations. Thorax (2006) 0.81

ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study. PLoS One (2007) 0.81

Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better. J Asthma Allergy (2013) 0.81

A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation. FASEB J (2012) 0.81

Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment. Ann Allergy Asthma Immunol (2015) 0.81

A mobile instrumentation platform to distinguish airway disorders. J Breath Res (2013) 0.81

Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma. Curr Opin Pediatr (2010) 0.81

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction. Thorax (2013) 0.80

Loss of asthma control in pediatric patients after discontinuation of long-acting Beta-agonists. Pulm Med (2012) 0.80

Wnt/β-catenin signaling modulates human airway sensitization induced by β2-adrenoceptor stimulation. PLoS One (2014) 0.80

Management of asthma in the elderly patient. Clin Interv Aging (2013) 0.80

Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results. BMC Pulm Med (2011) 0.80

Outpatient management of asthma in children. Clin Med Insights Pediatr (2013) 0.80

Safety of long-acting beta-agonists: urgent need to clear the air remains. Eur Respir J (2009) 0.80

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Respir Res (2006) 0.80

New combination treatments in the management of asthma: focus on fluticasone/vilanterol. J Asthma Allergy (2014) 0.80

Inhaled Corticosteroids. Pharmaceuticals (Basel) (2010) 0.79

LABA monotherapy in asthma: an avoidable problem. Br J Gen Pract (2013) 0.79

Pharmacogenetics of the beta 2-adrenergic receptor gene. Immunol Allergy Clin North Am (2007) 0.79

Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients. Qual Life Res (2014) 0.79

Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation. BMC Complement Altern Med (2013) 0.79

Stepping down asthma treatment: how and when. Curr Opin Pulm Med (2012) 0.78

Beta2 déjà vu. Chest (2006) 0.78

Comments on the Salmeterol Multicenter Asthma Research Trial. Chest (2006) 0.78

Articles by these authors

Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33

Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet (2012) 5.82

Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol (2004) 5.57

Genomic screening and replication using the same data set in family-based association testing. Nat Genet (2005) 5.44

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med (2014) 4.95

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85

PBAT: tools for family-based association studies. Am J Hum Genet (2004) 4.68

Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med (2009) 4.64

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA (2012) 4.30

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol (2004) 4.17

Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol (2007) 3.97

MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96

Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr (2007) 3.89

Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med (2011) 3.80

A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet (2009) 3.78

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol (2010) 3.54

A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics (2003) 3.52

Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50

Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet (2009) 3.41

Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr (2007) 3.40

On the replication of genetic associations: timing can be everything! Am J Hum Genet (2008) 3.32

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) (2007) 2.83

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet (2002) 2.76

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62

Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med (2008) 2.61

Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet (2001) 2.61

A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56

Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet (2009) 2.56

A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol (2009) 2.53

Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol (2010) 2.51

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol (2006) 2.49

The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet (2005) 2.46

Uric acid and the development of hypertension: the normative aging study. Hypertension (2006) 2.45

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial. Thorax (2013) 2.44

Obesity and asthma. Am J Respir Crit Care Med (2006) 2.43

Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med (2003) 2.39

Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med (2013) 2.36

The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet (2007) 2.35

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial. Eur Urol (2012) 2.34

Minimal haplotype tagging. Proc Natl Acad Sci U S A (2003) 2.28

Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in mexican children. PLoS Genet (2009) 2.27

Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol (2010) 2.27

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med (2009) 2.27

Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Natl Cancer Inst (2003) 2.26

Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med (2004) 2.24

Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet (2002) 2.23

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2004) 2.22

Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records. J Am Med Inform Assoc (2009) 2.20

Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol (2010) 2.20

The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet (2004) 2.19

Using the noninformative families in family-based association tests: a powerful new testing strategy. Am J Hum Genet (2003) 2.18

Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol (2005) 2.16

Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet (2002) 2.15

A family-based association test for repeatedly measured quantitative traits adjusting for unknown environmental and/or polygenic effects. Stat Appl Genet Mol Biol (2004) 2.15

Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet (2004) 2.14

Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. J Allergy Clin Immunol (2004) 2.11

Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. Am J Respir Crit Care Med (2009) 2.10

Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet (2011) 2.10

Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol (2005) 2.08

Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet (2004) 2.03

Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost (2005) 2.03

Parental stress as a predictor of wheezing in infancy: a prospective birth-cohort study. Am J Respir Crit Care Med (2002) 2.02

Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med (2003) 1.98

Pharmacogenomics: challenges and opportunities. Ann Intern Med (2006) 1.96

Filaggrin mutations confer susceptibility to atopic dermatitis but not to asthma. J Allergy Clin Immunol (2007) 1.93

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med (2002) 1.92

A new powerful non-parametric two-stage approach for testing multiple phenotypes in family-based association studies. Hum Hered (2003) 1.89

Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med (2012) 1.88

Transcriptomic analysis of human lung development. Am J Respir Crit Care Med (2009) 1.87

Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation (2002) 1.85

An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med (2012) 1.85

Asthma in Hispanics. Am J Respir Crit Care Med (2005) 1.84

Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol (2013) 1.80

Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J Allergy Clin Immunol (2008) 1.80

Ethnicity and skin test reactivity to aeroallergens among asthmatic children in Connecticut. Chest (2004) 1.79

Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med (2011) 1.76

Blood pressure, cerebral blood flow, and brain volumes. The SMART-MR study. J Hypertens (2010) 1.74

Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics (2003) 1.74

Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol (2007) 1.73

Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med (2005) 1.72

Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics (2004) 1.72

Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol (2003) 1.69

Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. Am J Respir Crit Care Med (2014) 1.69

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial. Thorax (2011) 1.69

Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases. Thorax (2007) 1.67

Relation between adiposity and hypertension persists after onset of clinically manifest arterial disease. J Hypertens (2012) 1.66

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest (2005) 1.66

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med (2013) 1.66